Hide

FocusBar

Subscribe to Premium Member
Switch to:
Insider Position Date Buy/Sell Shares Shares Owned Following This Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Details
SWILEY THOMAS SEVP, Chief Lending Officer2013-04-29Buy3,50060,000$18.4564.64.61Link
McCall James BrianDirector2013-04-29Buy3,50055,344$18.5364.94.16Link
McCarley James BDirector2013-04-29Buy1,00079,701$18.1118.16.57Link
Sockwell V KeithDirector2013-04-29Sell5,30040,465$18.2796.85.64Link
Hanigan Kevin JPresident/CEO
(Click for the stocks that their CEOs have bought)
2013-04-29Buy2,000165,400$18.0336.17.04Link
McKee Pathie EEVP/CFO2013-02-13Buy1,00072,124$2020-3.5Link
Almy Scott AEVP, Chief Risk Officer2013-02-12Buy5,00027,000$19.9199.6-3.06Link
LEVECCHIO ANTHONY JDirector2013-02-12Buy2,00040,990$19.9840-3.4Link
McCarley James BDirector2013-02-12Buy1,00073,701$20.2520.3-4.69Link
Hanigan Kevin JPresident/CEO2013-02-12Buy1,50083,400$2030-3.5Link
Sockwell V KeithDirector2012-08-29Sell3,72540,765$18.9170.42.06Link
McKee Pathie EEVP/CFO2012-08-27Sell1,40068,947$18.7526.32.93Link
Basham Gary DDirector2012-05-30Buy20057,420$16.183.219.28Link
Parks James CEVP/COO2012-05-23Sell3,22654,479$15.6450.523.4Link
Sockwell V KeithDirector2012-05-23Sell2,60040,376$15.5240.424.36Link
Ersman Jack DDirector2012-05-02Sell4,65053,817$16.1575.119.5Link
Basham Gary DDirector2012-05-01Sell3,33057,220$16.3554.418.04Link
Williamson Mark LEVP/Chief Credit Officer2011-08-23Buy9,00010,012$119975.45Link
McCall James BrianDirector2011-08-23Buy2,50012,500$11.3328.370.34Link
Base Garold RPRESIDENT & CEO2011-08-22Buy2,000217,833$10.9521.976.26Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.


GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
Free 7-day Trial
FEEDBACK